Global molecular landscape of early MASLD progression in human obesity
eLife · 2026
DOI: 10.7554/elife.109534 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Qing Zhao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Fatty Liver, Obesity, Obesity, Morbid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Swedish Research Council, Swedish Cancer Society.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is often asymptomatic early on but can progress to irreversible conditions like cirrhosis. Due to limited access to human liver biopsies, systematic and integrative molecular resources remain scarce. In this study, we performed transcriptomic analyses on liver and metabolomic analyses on liver and plasma samples from morbidly obese individuals without liver pathology or at early-stage MASLD. While the plasma metabolomic profile did not fully mirror liver histological features, dual-omics integration of liver samples revealed significantly remodeled lipid and amino acid metabolism pathways. Integrative network analysis uncoupled metabolic remodeling and gene expression as independent features of hepatic steatosis and fibrosis progression, respectively. Notably, GTPases and their regulators emerged as a novel class of genes linked to early liver fibrosis. This study offers a detailed molecular landscape of early MASLD in obesity and highlights potential targets of obesity-linked liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
- Cardiovascular & Metabolic Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Anatomy and Physiology, School of Biomedical Sciences, Faculty of Medicine Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
- Department of Hepatology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
- Department of Clinical Sciences Malmö and Lund University Diabetes Centre (LUDC), Lund University, Clinical Research Centre (CRC), Malmö, Sweden.
ORCID-Profile: Qing Zhao, Gabriele Sakalauskaite, Li Na Zhao, Sungdong Lee, Guoshou Teo, Volker M Lauschke, Hyungwon Choi, Philipp Kaldis
Förderung
- Novo Nordisk Foundation
- Swedish Research Council
- Swedish Cancer Society
- Crafoord Foundation
- Swedish Foundation for Strategic Research
- Swedish Research Council, Strategic Research Area
- Innovative Medicines Initiative 2 Joint Undertaking
- IngaBritt och Arne Lundbergs Forskningsstiftelse
Zitieren
APA
Zhao, Q., De Nardo, W., Wang, R., Zhong, Y., Keles, U., Sakalauskaite, G., Zhao, L. N., Tay, H., Youhanna, S., Yan, M., Xie, Y., Kim, Y., Lee, S., Lim, R. L., Teo, G., Narayanaswamy, P., Burton, P. R., Lauschke, V. M., Choi, H., …, & Kaldis, P. (2026). Global molecular landscape of early MASLD progression in human obesity. eLife. https://doi.org/10.7554/elife.109534
Vancouver
Zhao Q, De Nardo W, Wang R, Zhong Y, Keles U, Sakalauskaite G, et al. Global molecular landscape of early MASLD progression in human obesity. eLife. 2026. doi:10.7554/elife.109534
BibTeX
@article{Zhao2026,
author = {Zhao, Qing and De Nardo, William and Wang, Ruoyu and Zhong, Yi and Keles, Umur and Sakalauskaite, Gabriele and Zhao, Li Na and Tay, Huiyi and Youhanna, Sonia and Yan, Mengchao and Xie, Ye and Kim, Youngrae and Lee, Sungdong and Lim, Rachel Liyu and Teo, Guoshou and Narayanaswamy, Pradeep and Burton, Paul R and Lauschke, Volker M and Choi, Hyungwon and Watt, Matthew J and Kaldis, Philipp},
title = {Global molecular landscape of early MASLD progression in human obesity},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.109534}
}
EUVIMED